RSV vaccines safe and effective, Cochrane review finds
The review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting groups who are most at risk for serious illness, including older adults and infants.
RSV is a common virus that causes coughs and colds but can also lead to life-threatening lung infections like pneumonia. Children under the age of two months are at the highest risk of severe RSV infection and death, with older adults also vulnerable to severe disease.
An international group of researchers analysed 14 ...